menu
European Commission
This project has received funding from the
European Union’s Seventh Framework Programme
for research, technological development and demonstration.
agence de communication Lyon
menu

    TumAdoR PROJECT

    Developing New Therapeutic Monoclonal Antibodies to neutralize Adenosine immunosuppressive pathway in tumour context

    Based on the broad immuno-suppression and strong tumour promotion (proliferation and dissemination) exerted by Adenosine, therapeutic strategies aimed at inhibiting Adenosine are highly promising

    Events
    News

    08 September 2015 M24 meeting in München

    Genewake organizes its The TumAdoR M24 meeting in München (Germany), on 9 and 10 September 2015. Program here.More >>


    26 February 2015 M18 meeting in Marseille

    The TUMADOR consortium organizes its M18 meeting in Marseille, France on 26 and 27 February 2015. Program here.More >>


    Displaying results 1 to 2 out of 3
    Brochure